Latest Ratios: P/E Ratio 20.9x · EV/EBITDA 15.4x · ROE 9.1%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.1B | $915M | $944M | $1.2B | $1.4B | $2.1B | $1.3B | $1.1B | $882M | $658M | $705M |
| Enterprise Value | $1.5B | $1.3B | $1.3B | $1.6B | $1.8B | $2.4B | $1.6B | $1.3B | $1.1B | $827M | $854M |
| P/E Ratio → | 20.88 | 21.36 | 21.31 | 37.28 | 32.92 | 58.12 | 33.24 | 31.63 | 27.22 | 28.92 | 31.12 |
| P/S Ratio | 5.01 | 4.70 | 4.92 | 7.04 | 8.58 | 14.80 | 8.99 | 7.95 | 6.39 | 5.03 | 5.31 |
| P/B Ratio | 2.09 | 1.85 | 2.11 | 2.76 | 3.46 | 5.73 | 3.66 | 3.28 | 3.51 | 2.84 | 3.19 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | 16.98 | 14.62 | 16.08 | 22.19 | 22.71 | 64.13 | 23.87 | 29.67 | 19.24 | 15.36 | 14.98 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 6.83 | 6.91 | 9.51 | 10.81 | 17.08 | 10.99 | 9.89 | 7.88 | 6.32 | 6.43 |
| EV / EBITDA | 15.36 | 15.30 | 16.32 | 23.03 | 23.48 | 40.75 | 26.72 | 25.24 | 20.55 | 15.71 | 15.87 |
| EV / EBIT | 27.16 | 21.46 | 20.71 | 36.53 | 33.32 | 66.96 | 41.20 | 38.18 | 28.05 | 21.36 | 21.82 |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.2% | 39.2% | 51.9% | 50.0% | 51.3% | 48.5% | 50.0% | 49.5% | 48.2% | 50.6% | 50.7% |
| Operating Margin | 27.9% | 27.9% | 27.7% | 23.6% | 29.1% | 23.2% | 26.4% | 26.4% | 26.9% | 28.9% | 30.3% |
| Net Profit Margin | 22.0% | 22.0% | 23.1% | 19.0% | 26.1% | 25.5% | 27.1% | 25.2% | 23.5% | 17.4% | 17.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.1% | 9.1% | 10.2% | 7.6% | 11.0% | 10.2% | 11.4% | 11.7% | 13.4% | 10.1% | 10.6% |
| ROA | 3.3% | 3.3% | 3.6% | 2.7% | 4.1% | 3.7% | 4.1% | 4.0% | 4.5% | 3.6% | 3.8% |
| ROIC | 4.7% | 4.7% | 4.8% | 3.7% | 4.9% | 3.8% | 4.6% | 5.1% | 6.5% | 7.4% | 8.4% |
| ROCE | 4.4% | 4.4% | 4.6% | 3.8% | 4.9% | 3.5% | 4.2% | 4.7% | 5.8% | 6.5% | 7.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.84 | 0.84 | 0.86 | 0.97 | 0.91 | 0.89 | 0.83 | 0.81 | 0.83 | 0.75 | 0.69 |
| Debt / EBITDA | 4.80 | 4.80 | 4.75 | 6.00 | 4.91 | 5.51 | 4.94 | 5.00 | 3.94 | 3.30 | 2.84 |
| Net Debt / Equity | — | 0.84 | 0.85 | 0.96 | 0.90 | 0.88 | 0.81 | 0.80 | 0.82 | 0.73 | 0.67 |
| Net Debt / EBITDA | 4.77 | 4.77 | 4.70 | 5.97 | 4.85 | 5.45 | 4.86 | 4.96 | 3.87 | 3.21 | 2.76 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | 4.33 | 4.33 | 5.01 | 4.04 | 7.48 | 6.69 | 10.87 | 8.47 | 7.19 | 8.06 | 8.38 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.45 | 0.45 | 0.52 | 1.05 | 0.32 | 0.61 | 0.60 | 0.45 | 0.33 | 0.45 | 0.57 |
| Quick Ratio | 0.36 | 0.36 | 0.44 | 0.98 | 0.26 | 0.51 | 0.51 | 0.36 | 0.27 | 0.39 | 0.48 |
| Cash Ratio | 0.03 | 0.03 | 0.05 | 0.02 | 0.03 | 0.06 | 0.08 | 0.03 | 0.04 | 0.08 | 0.08 |
| Asset Turnover | — | 0.14 | 0.15 | 0.13 | 0.15 | 0.14 | 0.15 | 0.15 | 0.18 | 0.20 | 0.21 |
| Inventory Turnover | 15.68 | 15.68 | 13.75 | 11.92 | 12.80 | 13.75 | 13.85 | 12.48 | 13.23 | 15.70 | 16.01 |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.4% | 2.7% | 2.5% | 1.9% | 1.5% | 0.9% | 1.4% | 1.5% | 1.7% | 2.1% | 1.9% |
| Payout Ratio | 58.2% | 58.2% | 52.8% | 71.2% | 49.0% | 53.0% | 47.3% | 47.7% | 46.0% | 61.4% | 57.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.8% | 4.7% | 4.7% | 2.7% | 3.0% | 1.7% | 3.0% | 3.2% | 3.7% | 3.5% | 3.2% |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 2.4% | 2.7% | 2.5% | 1.9% | 1.5% | 0.9% | 1.4% | 1.5% | 1.7% | 2.1% | 1.9% |
| Shares Outstanding | — | $18M | $18M | $18M | $18M | $18M | $18M | $17M | $17M | $16M | $16M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MSEX stock.
Middlesex Water Company's current P/E ratio is 20.9x. The historical average is 25.7x. This places it at the 23th percentile of its historical range.
Middlesex Water Company's current EV/EBITDA is 15.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.8x.
Middlesex Water Company's return on equity (ROE) is 9.1%. The historical average is 9.5%.
Based on historical data, Middlesex Water Company is trading at a P/E of 20.9x. This is at the 23th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Middlesex Water Company's current dividend yield is 2.41% with a payout ratio of 58.2%.
Middlesex Water Company has 39.2% gross margin and 27.9% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Middlesex Water Company's Debt/EBITDA ratio is 4.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
PFAS compliance cost recovery
Metrics are mathematically derived from official filings.
Premium Multiple Outruns Earnings Visibility
Based on MSEX's reported figures, the trailing P/E of 25.37 and forward P/E of 21.26 sit well above the 15.56 to 26.70 peer range, and with a 2.3% dividend yield, the market appears to be pricing in regulatory recovery success rather than current earnings power.
A P/E near 25 for a regulated water utility is more typical of growth-oriented equities than of a bond-proxy whose earnings are anchored to an authorized return, which suggests investors are capitalizing expected rate base expansion from PFAS-related capital spending. The compression from trailing to forward P/E implies the market expects earnings to rise, but the reported PEG of 15.86 indicates the growth premium is not supported by current growth rates. Investors should monitor whether NJ BPU outcomes validate this expectation, as the valuation has limited margin for error.
Earned Returns Lag Regulated Expectations
Based on reported figures, MSEX's quarterly ROE ranged from 1.8% to 3.4% across the ten quarters shown, a level that appears low relative to the typical authorized ROEs granted to water utilities and well below the 9.4% to 13.5% earned by most listed peers.
Persistently low earned ROE on a rate base of roughly $1.1B to $1.2B implies that either allowed returns are being eroded by regulatory lag and non-recovered costs, or that the reported equity base is inflated relative to recoverable investment. The gap between authorized and earned returns is the primary analytical question here, and the data does not allow us to confirm which explanation dominates. Investors should treat the low ROE as a warning signal requiring confirmation from authorized ROE disclosures in recent rate orders.
Margin Swings Signal Uneven Recovery Timing
As reported in financial statements, MSEX's operating margin moved from 22.4% in 2024Q4 to 37.0% in 2026Q3, a 14.6-point swing that appears to reflect the timing of regulatory recovery against operating and PFAS-related costs rather than structural change.
Operating margin expansion from the 2025 trough to 2026 is consistent with rate relief arriving ahead of cost increases, yet the reversal in 2025Q4 demonstrates how quickly that benefit can disappear when costs step up. Net margin tracking a similar pattern suggests the swings are operational and regulatory in origin rather than driven by below-the-line items. Investors should monitor whether margins stabilize above the mid-20s once PFAS treatment costs enter the rate base.
Deleveraging Reflects Equity Growth Rather Than Repayment
Based on MSEX's reported figures, debt-to-capital held near 0.44 to 0.50 while interest coverage ranged from 3.51x to 6.25x, and FFO-to-debt moved between 5.24% and 8.09%, indicating moderate credit metrics that are adequate but not strong for a regulated utility.
The stable debt-to-capital ratio alongside a declining debt-to-equity figure suggests the improvement is driven by equity accumulation from retained earnings and issuance rather than meaningful debt reduction, which is a different credit story. FFO-to-debt in the mid-single digits sits at the low end of what typically supports a stable credit profile for a utility of this size, which may constrain financing flexibility during the PFAS capital program. The data does not provide regulatory capital structure limits, so the adequacy of these ratios relative to the NJ BPU's allowed equity ratio remains an open question.
Payout Ratio Tightens as Earnings Recover
According to recent SEC filings as summarized here, MSEX's dividend payout ratio fell from 76.9% in 2025Q4 to 37.9% in 2026Q3, while dividend yield held near 0.5% to 0.7% on quarterly figures and the current 2.3% annual yield reflects the trailing dividend against the current share price.
The sharp decline in payout ratio from its 2024 to 2025 highs reflects earnings recovery rather than any dividend reduction, and the 37.9% level leaves room for internal funding of CAPEX. However, the elevated payout observed in earlier quarters indicates that the dividend was previously absorbing a large share of earnings while the company funded a significant investment program. Investors should assess whether sustained earnings growth can keep payout ratios in a comfortable range once quarterly earnings normalize from the 2026 peak.
Standard P/E Obscures Regulatory Return Dynamics
Based on reported figures, applying an industrial-style P/E or growth-based PEG of 15.86 to MSEX mischaracterizes a bond-proxy whose value is set by the authorized ROE and rate base growth, and the more informative adjustment is price-to-book relative to earned ROE.
Comparing MSEX's 25.37 P/E to non-utility benchmarks overstates the growth implied by its earnings, since regulated returns are capped and the PEG framework assumes growth that the regulatory compact does not guarantee. A more appropriate lens is the spread between earned ROE of roughly 2% to 3% and the cost of equity, combined with the 2.20 price-to-book, which together indicate the market is paying a premium over book value for returns that currently fall short of typical authorized levels. This framing suggests the valuation hinges on whether earned ROE converges upward toward authorized levels, a conclusion that warrants further investigation rather than being treated as established.